Project Grant HT9425261E056
Award Date 6/1/26
Completion Date 5/31/30
Dollars Obligated $958K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Buffalo, NY 14203, USA
Similar Awards
- Federal Project Grant Award Summary Health Research, Inc., operating as Health Research At Roswell Park in Buffalo, New York, received a $929,806 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2029. The award supports research focused on leveraging infiltrating myeloid cells to improve therapeutic response to bite-secreting T cells in ovarian cancer treatment. This research...
- Federal Grant Award Summary Health Research, Inc., operating as Health Research At Roswell Park in Buffalo, New York, received a $173,500 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2027. The award supports research focused on improving chemotherapy efficacy for small cell carcinomas of the bladder, a rare cancer type with significant clinical relevance to military...
- Health Research, Inc., operating as Health Research At Roswell Park, received a $1,152,194 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2029. The award supports research aimed at leveraging infiltrating myeloid cells to improve therapeutic response to bispecific T-cell engaging (BiTE) antibody-secreting T cells in ovarian cancer treatment. This four-year initiative...
- Federal Grant Award Summary Health Research, Inc., operating as Health Research At Roswell Park, received a $2.39M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded June 1, 2026, with a completion date of May 31, 2030. The project, titled "Stress, Lifestyle, and Immune Pathways in Aggressive Breast Cancer: An Epitranscriptomic Study," will be conducted at the organization's Buffalo, New York location....
- This Project Grant award of $695,386.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by Health Research, Inc. (Roswell Park Division) to investigate translation dysregulation in metastatic breast cancer. The project aims to evaluate the implications of this phenomenon for disease outcomes and immunotherapy responses. The award period runs from March 1, 2024 to February 28, 2027. As a prime grantee,...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $352,000 under the Military Medical Research and Development program (CFDA 12.420) to the Sloan-Kettering Institute for Cancer Research for the project period September 1, 2025, through August 31, 2027. The award supports research focused on augmenting the in vivo efficacy of a novel lanosterol synthase inhibitor in glioblastoma treatment. This research aligns with the DHA's mission to transform healthcare for service...
- Health Research, Inc. Inc Roswell Park Division Health Research Division (the Division) was awarded a $693,987 project grant from the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420). The grant will fund cancer immunotherapy research from June 1, 2023 through May 31, 2026. Specifically, the Division will investigate strategies to counter solid tumor antigen immune escape using CAR T cell therapies. As a past recipient of Defense Health Agency...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Sloan-Kettering Institute for Cancer Research a Project Grant totaling $1,387,727 under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025, through August 31, 2029. The award funds research titled "Integrated Immunomodulatory Analysis of LAG3 Inhibition in Renal Cell Carcinoma," conducted at the Institute's facility in New York, NY. This research project focuses...
- Health Research, Inc. Roswell Park Division received a $559,647 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research using microfluidic lung cancer models. The two-year award, made on June 1, 2023 and set to conclude on May 31, 2025, will support investigating novel drug resistance mechanisms in lung cancer through "Microfluidic Lung Cancer On A Chip" models. As a past recipient of Defense...
- The U.S. Department of Defense's Defense Health Agency awarded Health Research, Inc. a $1,545,300 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "TARGETING MYCAF-DRIVEN CASTRATION-RESISTANT PROSTATE TUMOR GROWTH." The award, which has a performance period of May 1, 2024 to April 30, 2027, will enable Health Research, Inc.'s Roswell Park Division to perform biomedical research and provide scientific services to advance...